VMI
CCXI

VHCP Management II’s ChemoCentryx, Inc. CCXI Stock Holding History

VHCP Management II’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-23,064
Closed -$292K – 22
2018
Q3 		$292K Hold
23,064
– – 0.08% 21
2018
Q2 		$304K Buy
+23,064
New +$276K 0.09% 18

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VHCP Management II's CCXI Position: Q4 2018 in Review

VHCP Management II sold out of ChemoCentryx, Inc. (CCXI) in Q4 2018, closing a stake of 23,064 shares — an estimated $292K sold.

VHCP Management II first reported a position in CCXI in Q2 2018 and held it in 2 quarters. The position peaked at $304K in Q2 2018. 108 funds tracked by Wall St. Rank hold CCXI as of Q4 2018.

  • VHCP Management II reported no remaining ChemoCentryx, Inc. position as of Q4 2018 after selling out during the quarter.
  • VHCP Management II sold 23,064 ChemoCentryx, Inc. shares in Q4 2018, an estimated $292K.
  • VHCP Management II first reported a position in ChemoCentryx, Inc. in Q2 2018 and held it in 2 quarters.
  • VHCP Management II's ChemoCentryx, Inc. position peaked at $304K in Q2 2018.
  • 108 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2018.

Based on VHCP Management II's 13F filing for Q4 2018, filed 13 Feb 2019.